Medical Science Liaison, Lymphoma (Lacutamab)

At Sobi, we believe diversity drives innovation and inclusion creates stronger teams. We are committed to building a workplace where everyone feels valued and empowered to contribute. If this role excites you but you’re unsure if you meet every requirement, we encourage you to apply. Your unique perspective and experiences could be exactly what we need. We look forward to hearing from you! At Sobi, each person brings their unique talents to work as a team and make a difference. We are dedicated to developing and delivering innovative therapies to improve the lives of people who live with a rare disease. Our edge comes from our team of people and our commitment to patients. Our mission and culture at Sobi North America get us excited to come to work every day, but here are a few more reasons to join our team: - Competitive compensation for your work - Generous time off policy - Opportunity to broaden your horizons by attending popular conferences - Emphasis on work/life balance - Collaborative and team-oriented environment - Making a positive impact to help ultra-rare disease patients who are in need of life saving treatments As the Medical Science Liaison (MSL), Lymphoma (Lacutamab) , you will be a field-based scientific expert for cutaneous T-cell lymphoma ( CTCL ) and lacutamab, a humanized monoclonal antibody immunotherapy targeting KIR3DL2. You will build trusted scientific relationships, exchange balanced medical information, and generate actionable insights that inform US Medical Affairs strategy and launch readiness. You will support Sobi's rare disease portfolio in the hematology franchise and serve as a trusted scientific resource across the hematology-oncology, dermatology, and dermato-oncology communities. You will collaborate with academic, community, and multidisciplinary care teams, always in accordance with regulatory, legal, and compliance requirements.

This is a field execution role within Hematology Medical Affairs. You will contribute insights and a field perspective to the CTCL medical strategy, which is led by Medical Affairs leadership. What You Will Do Scientific Engagement and External Relationships - Serve as a primary field-based scientific point of contact for Sobi Medical Affairs within your assigned geography. - Develop and maintain meaningful, two-way relationships with opinion leaders, healthcare professionals, medical organizations, investigators, and other stakeholders involved in CTCL care. - Exchange accurate, fair, balanced, and scientifically rigorous information on CTCL, lacutamab, relevant clinical data, disease biology, treatment approaches, and the evolving care landscape. - Engage across academic, community, and multidisciplinary settings, including hematology-oncology, dermatology, and dermato-oncology practices. - Respond appropriately to unsolicited scientific inquiries and connect stakeholders with Sobi resources in line with applicable policies and procedures. Medical Insights and Strategy Execution - Identify, document, and share high-quality field insights on unmet needs, clinical practice, patient pathways, evidence gaps, stakeholder perspectives, competitive developments, and the treatment landscape. - Partner with Medical Affairs leadership and cross-functional colleagues to interpret insights and inform adjustments to medical strategy, tactics, educational priorities, and engagement plans. - Execute territory-level medical plans aligned with the US CTCL and lacutamab medical strategy, adapting engagement to local and regional stakeholder needs. - Support key institution and stakeholder engagement planning, helping establish Sobi as a trusted scientific partner in CTCL. Launch Readiness, Education, and Congress Support - Contribute to lacutamab launch preparedness through disease-state education, articulation of unmet need, scientific exchange, stakeholder mapping, and field execution of approved medical tactics.